Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

Llovet, Josep, Brú, Concepció, Bruix, Jordi · 1999 · Seminars in Liver Disease

Abstract

The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-2007-1007122

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 3,805

Metadata

Authors
Llovet, J., Brú, C., & Bruix, J.
Affiliations
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Venue
Seminars in Liver Disease
Published
1999
Volume
19
Issue
03
Pages
329-338
ISSN
  • 0272-8087 (ISSN-L)
  • 1098-8971
OpenAlex
W2147172608
Cited by
3,805
References
0
Citations by year
2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
FWCI
11.18
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Liver Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Keywords
hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
MeSH terms
Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification. https://app.cochat.ai/papers/10.1055/s-2007-1007122
The paper
Llovet, J., Brú, C., & Bruix, J. (1999). Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification. Seminars in Liver Disease. https://doi.org/10.1055/s-2007-1007122

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.